Evidence map

ArticleMedComm2025

A New N6-Methyladenosine Inhibitor, Celastrol, Alleviates Rheumatoid Arthritis via Targeting IGF2BP3.

Qishun Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41164801